Michala Zgarbova
Prague, PR 12844, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Allosteric Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase Based on N,N'-Diphenylurea.
Journal: ChemMedChem
Published: July 25, 2025
Discovery of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors based on adenosine 5'-carboxamides.
Journal: RSC medicinal chemistry
Published: June 10, 2024
The zymogenic form of SARS-CoV-2 main protease: A discrete target for drug discovery.
Journal: The Journal of biological chemistry
Published: June 07, 2024
Developing Allosteric Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase.
Journal: ChemMedChem
Published: May 14, 2024
Inhibitors of mpox VP39 2'-O methyltransferase efficiently inhibit the monkeypox virus.
Journal: Antiviral research
Published: August 08, 2023
Ebselen derivatives inhibit SARS-CoV-2 replication by inhibition of its essential proteins: PLpro and Mpro proteases, and nsp14 guanine N7-methyltransferase.
Journal: Scientific reports
Published: April 11, 2022
A Helquat-like Compound as a Potent Inhibitor of Flaviviral and Coronaviral Polymerases.
Journal: Molecules (Basel, Switzerland)
Published: February 21, 2022
Discovery of Modified Amidate (ProTide) Prodrugs of Tenofovir with Enhanced Antiviral Properties.
Journal: Journal of medicinal chemistry
Published: October 29, 2021
Triterpenoid-PEG Ribbons Targeting Selectivity in Pharmacological Effects.
Journal: Biomedicines
Published: June 18, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026